Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipotoxicity.

J M Weinberg1

  • 1Division of Nephrology, Department of Internal Medicine, Veterans Affairs Ann Arbor Healthcare System and University of Michigan, Ann Arbor, Michigan, USA. wnberg@umich.edu

Kidney International
|September 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase III randomized study of the proposed adalimumab biosimilar GP2017 in psoriasis: impact of multiple switches.

The British journal of dermatology·2018
Same author

A spectral line discriminator interferometer: an analysis.

Applied optics·2010
Same author

Parvovirus b19 infection associated with acute hepatitis, arthralgias, and rash.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Same author

A novel vaccine (Zostavax) to prevent herpes zoster.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia·2008
Same author

Areolar and periareolar pityriasis versicolor.

Journal of the European Academy of Dermatology and Venereology : JEADV·2004
Same author

Granuloma annulare restricted to Becker's naevus.

The British journal of dermatology·2004
Same journal

Crystal-Storing Histiocytosis Causing Severe AKI.

Kidney international·2026
Same journal

Peritoneal dialysis in a patient with extensive burn scarring.

Kidney international·2026
Same journal

COPA syndrome unmasked by anti-neutrophil cytoplasmic antibody-positive immune-complex nephritis.

Kidney international·2026
Same journal

Monitoring anti-nephrin antibodies in the management of recurrent diffuse podocytopathy.

Kidney international·2026
Same journal

The "Hear My Last Wish" Initiative: Leveraging Voiceprint Technology to Bridge the Gap Between Donor Intent and Family Consent in Taiwan.

Kidney international·2026
Same journal

A three-year randomized, double-blind, placebo-controlled study of lanreotide in stage 2/3 autosomal dominant polycystic kidney disease.

Kidney international·2026
See all related articles

Excess fatty acids cause cellular dysfunction and injury, a process called lipotoxicity, contributing to metabolic syndrome. In kidneys, nonesterified fatty acids (NEFA) worsen injury and disease progression.

Area of Science:

  • Cellular biology
  • Nephrology
  • Metabolic disorders

Background:

  • Excess fatty acids and triglycerides cause cellular dysfunction and injury, termed lipotoxicity, a key factor in metabolic syndrome.
  • Lipotoxicity affects multiple tissues, including heart, liver, and pancreas, impacting cellular energy and function.
  • In the kidney, nonesterified fatty acids (NEFA) contribute to tubule damage and inflammation, particularly in proteinuric states.

Purpose of the Study:

  • To investigate the role of NEFA in kidney injury and disease progression.
  • To explore the mechanisms of NEFA-induced mitochondrial dysfunction in renal tubule cells.
  • To evaluate the therapeutic potential of peroxisome proliferator-activated receptor alpha (PPARα) ligands in mitigating kidney lipotoxicity.

Main Methods:

Related Experiment Videos

  • Analysis of fatty acid and triglyceride accumulation in renal cells.
  • Assessment of mitochondrial function and beta-oxidation enzyme activity in kidney tissues.
  • In vivo studies using acute renal failure models and PPARα ligand treatment.

Main Results:

  • NEFA accumulation and triglyceride content increase in tubule cells during acute renal failure, linked to reduced beta-oxidation.
  • NEFA-induced mitochondrial dysfunction is a primary cause of proximal tubule energetic failure.
  • PPARα ligand treatment reduced NEFA and triglyceride levels, limiting kidney injury and inflammation.

Conclusions:

  • Lipotoxicity, driven by NEFA, significantly contributes to kidney damage and the progression of nephropathy.
  • Targeting NEFA metabolism and PPARα pathways offers a potential therapeutic strategy for kidney diseases.
  • Kidney disease shares systemic metabolic derangements with metabolic syndrome, highlighting interconnected pathophysiology.